Invention Grant
- Patent Title: Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF
-
Application No.: US15995518Application Date: 2018-06-01
-
Publication No.: US11769597B2Publication Date: 2023-09-26
- Inventor: Lorah Perlee , Sara Hamon , Charles Paulding
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: Armstrong Teasdale LLP
- Main IPC: G16H50/70
- IPC: G16H50/70 ; G16B20/00 ; C12Q1/6883 ; G16H50/50 ; G16H10/40 ; C12Q1/6827
Abstract:
Disclosed herein are methods and compositions for associating a genetic variant with intraretinal fluid. Also disclosed herein are methods and compositions for associating a genetic variant with visual acuity, anatomic outcomes or treatment frequency.
Public/Granted literature
Information query
